Mostrar el registro sencillo del ítem
Cross-talk between neurosteroid and endocannabinoid systems in cannabis addiction
| dc.rights.license | open | en_US |
| hal.structure.identifier | Neurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB] | |
| dc.contributor.author | VALLEE, Monique | |
| hal.structure.identifier | Neurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB] | |
| dc.contributor.author | RAUX, Pierre-Louis | |
| dc.date.accessioned | 2023-02-06T12:12:41Z | |
| dc.date.available | 2023-02-06T12:12:41Z | |
| dc.date.created | 2022 | |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/171871 | |
| dc.description.abstractEn | Steroids and endocannabinoids are part of two modulatory systems and some evidence has shown their interconnections in several functions. Homeostasis is a common steady-state described in the body, which is settled by regulatory systems to counterbalance deregulated or allostatic set points towards an equilibrium. This regulation is of primary significance in the central nervous system for maintaining neuronal plasticity and preventing brain-related disorders. In this context, the recent discovery of the shutdown of the endocannabinoid system (ECS) overload by the neurosteroid pregnenolone has highlighted new endogenous mechanisms of ECS regulation related to cannabis-induced intoxication. These mechanisms involve a regulatory loop mediated by overactivation of the central type-1 cannabinoid receptor (CB1R), which triggers the production of its own regulator, pregnenolone. Therefore, this highlights a new process of regulation of steroidogenesis in the brain. Pregnenolone, long considered an inactive precursor of neurosteroids, can then act as an endogenous negative allosteric modulator of CB1R. The present review aims to shed light on a new framework for the role of ECS in the addictive characteristics of cannabis with the novel endogenous mechanism of ECS involving the neurosteroid pregnenolone. In addition, this new endogenous regulatory loop could provide a relevant therapeutic model in the current context of increasing recreational and medical use of cannabis. © 2022 British Society for Neuroendocrinology. | |
| dc.language.iso | EN | en_US |
| dc.subject.en | Neurosteroids | |
| dc.subject.en | Pregnenolone | |
| dc.subject.en | Endocannabinoid system (ECS) | |
| dc.subject.en | Type-1 cannabinoid receptor (CB1R) | |
| dc.subject.en | Endocannabinoids (eCBs) | |
| dc.subject.en | Neuromodulation | |
| dc.subject.en | Cannabis addiction | |
| dc.title.en | Cross-talk between neurosteroid and endocannabinoid systems in cannabis addiction | |
| dc.title.alternative | J Neuroendocrinol. | en_US |
| dc.type | Document de travail - Pré-publication | en_US |
| dc.identifier.doi | 10.1111/jne.13191 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Neurosciences [q-bio.NC] | en_US |
| dc.identifier.pubmed | 36043319 | en_US |
| bordeaux.hal.laboratories | Neurocentre Magendie - U1215 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | INSERM | en_US |
| bordeaux.team | Physiopathologie et approches thérapeutiques des maladies liées au stress | en_US |
| bordeaux.identifier.funderID | Conseil Régional Aquitaine | en_US |
| bordeaux.identifier.funderID | Ministère de l'Enseignement Supérieur et de la Recherche Scientifique | en_US |
| hal.export | false | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.au=VALLEE,%20Monique&RAUX,%20Pierre-Louis&rft.genre=preprint |
